Clinical trial
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea.Observational Retrospective Study.
NCT00480974 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea.Observational Retrospective Study.
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell anemia, sickle cell thalassemia